Table 1.
Follow-up patient characteristics.
Table 2.
CSCH Overall patient characteristics.
Fig 1.
Follow-up and overall CSCH patient outcomes.
Fig 2.
Follow-up patient outcomes by age.
Fig 3.
Follow-up patient outcomes by primary treatment Hb level (g/dL).
Table 3.
Risk factors for VL relapse in all 36 follow-up patients.
Table 4.
Risk factors for VL relapse in 19 follow-up patients treated for primary VL at CSCH.
Table 5.
Risk factors for VL relapse in 248 overall CSCH patients.
Table 6.
Risk factors for PKDL in all 36 follow-up patients.
Table 7.
Risk factors for PKDL in 19 follow-up patients treated for primary VL at CSCH.